Century Therapeutics CEO Brent Pfeiffenberger forfeited 13,850 shares at $1.94 per share. The transaction left him with 3,633,839 shares and represented about 0.4% of his prior holding, giving investors the stated scale of the ownership change and the executive’s remaining position.

Key Highlights

  • The transaction represented about 0.4% of Brent Pfeiffenberger’s prior share holding.
  • SEC transaction code F was reported for the event.
  • The share forfeiture was recorded on September 11, 2026.

Century Therapeutics, Inc. (NASDAQ: IPSC) reported a transaction involving Brent Pfeiffenberger, who forfeited 13,850 shares. The transaction was reported at $1.94 per share.

September 11 Transaction Carries Code F

The transaction date was September 11, 2026. Its SEC transaction code was F. Pfeiffenberger is Century Therapeutics’ President and CEO. The reported per-share value was tied to the 13,850 shares covered by the transaction. The ownership change concerned Pfeiffenberger’s Century Therapeutics holdings.

Forfeiture Equalled About 0.4% of Prior Holding

The transaction represented about 0.4% of Pfeiffenberger’s prior share holding. After the transaction, he owned 3,633,839 shares of Century Therapeutics. That percentage compares the forfeited shares with Pfeiffenberger’s earlier holding. The stated post-transaction balance covers his remaining shares following the ownership change. Transaction code F denotes shares withheld or delivered to cover taxes or an exercise price.